Marker Therapeutics
MRKR · NASDAQ
$1.16−$0.04 (−3.33%)TodayMarket closed ·
Prev close $1.20
About MRKR
- Employees
- 5
- Headquarters
- Houston, Texas
- Listed
- Nov 8, 2016
- Sector
- Health Care
- Industry
- Biotechnology
- Website
- markertherapeutics.com
Leadership
| Name | Title | Since |
|---|---|---|
| N. David Eansor | — | — |
| Juan Vera | — | 2018 |
| Kathryn Corzo | — | — |
| Steven Elms | — | — |
| Katharine Knobil | — | — |
Suppliers and customers
Price correlation is over one year: 1 means the stocks move together, -1 opposite
| Company | Relationship | Correlation |
|---|---|---|
| Bio-Techne TECH | Supplier | 0.58 |
| Baylor College of Medicine | Supplier and customer | — |
| Wilson Wolf Manufacturing Corp. | Customer | — |
Similar companies
Companies in the same industry as Marker Therapeutics
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.